EP0832197A4 - Rekombinantes geflügelpockenvirus und seine verwendungsmöglichkeiten - Google Patents

Rekombinantes geflügelpockenvirus und seine verwendungsmöglichkeiten

Info

Publication number
EP0832197A4
EP0832197A4 EP96924336A EP96924336A EP0832197A4 EP 0832197 A4 EP0832197 A4 EP 0832197A4 EP 96924336 A EP96924336 A EP 96924336A EP 96924336 A EP96924336 A EP 96924336A EP 0832197 A4 EP0832197 A4 EP 0832197A4
Authority
EP
European Patent Office
Prior art keywords
recombinant fowlpox
fowlpox viruses
viruses
recombinant
fowlpox
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP96924336A
Other languages
English (en)
French (fr)
Other versions
EP0832197A1 (de
Inventor
Mark D Cochran
David E Junker
Philip A Singer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntro Corp
Original Assignee
Syntro Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntro Corp filed Critical Syntro Corp
Publication of EP0832197A1 publication Critical patent/EP0832197A1/de
Publication of EP0832197A4 publication Critical patent/EP0832197A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18141—Use of virus, viral particle or viral elements as a vector
    • C12N2760/18143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP96924336A 1995-06-07 1996-06-04 Rekombinantes geflügelpockenvirus und seine verwendungsmöglichkeiten Withdrawn EP0832197A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US484790 1983-04-14
US48479095A 1995-06-07 1995-06-07
PCT/US1996/011187 WO1996040880A1 (en) 1995-06-07 1996-06-04 Recombinant fowlpox viruses and uses thereof

Publications (2)

Publication Number Publication Date
EP0832197A1 EP0832197A1 (de) 1998-04-01
EP0832197A4 true EP0832197A4 (de) 2002-10-16

Family

ID=23925610

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96924336A Withdrawn EP0832197A4 (de) 1995-06-07 1996-06-04 Rekombinantes geflügelpockenvirus und seine verwendungsmöglichkeiten

Country Status (5)

Country Link
EP (1) EP0832197A4 (de)
JP (1) JPH11507241A (de)
AU (1) AU729518B2 (de)
CA (1) CA2223591A1 (de)
WO (1) WO1996040880A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6518298A (en) * 1997-03-28 1998-10-22 Nippon Zeon Co., Ltd. Novel dna vector and vaccines containing novel recombinant dna vectors as the active ingredient
EP0974660A1 (de) * 1998-06-19 2000-01-26 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Newcastle-Krankheitsvirus Infektiöser Klone, Impfstoffe und Diagnosetest
WO2001089559A2 (en) * 2000-05-24 2001-11-29 Merial Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine
WO2002102404A1 (en) * 2001-06-18 2002-12-27 Institut National De La Recherche Agronomique Uses of cytokines
CN1330376C (zh) * 2001-09-30 2007-08-08 扬州大学 重组鸡痘病毒联合疫苗
DE10221411B4 (de) * 2002-05-14 2004-07-08 GSF-Forschungszentrum für Umwelt und Gesundheit GmbH Rekombinantes Fowlpox-Virus
GB2402391A (en) * 2003-06-04 2004-12-08 Oxxon Pharmaccines Ltd Fowlpox recombinant genome
US7527960B2 (en) 2004-06-25 2009-05-05 Merial Limited Avipox recombinants expressing foot and mouth disease virus genes
US9839684B2 (en) 2011-04-06 2017-12-12 Biovaxim Limited Pharmaceutical compositions comprising inactivated HIV viral particles and non-pathogenic lactobacilli for the induction of antigen-specific immunotolerance
JP2014236748A (ja) * 2014-08-26 2014-12-18 一般財団法人阪大微生物病研究会 組換え多価ワクチン

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988000971A1 (en) * 1986-08-01 1988-02-11 Commonwealth Scientific And Industrial Research Or Recombinant vaccine
EP0520753A1 (de) * 1991-06-28 1992-12-30 THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF AGRICULTURE Rekombinante Geflügelpockenvazzine zum Schutz gegen die Marek-Krankheit
US5258294A (en) * 1988-02-12 1993-11-02 Commonwealth Scientific And Industrial Research Organisation Bidirectional pox virus promoter element
WO1994016716A1 (en) * 1993-01-21 1994-08-04 Virogenetics Corporation Recombinant virus immunotherapy
WO1994019015A1 (en) * 1993-02-26 1994-09-01 Syntro Corporation Recombinant fowlpox viruses and uses thereof
US5403582A (en) * 1993-01-21 1995-04-04 Nippon Zeon Co., Ltd. Vaccine comprising fowlpox virus recombinants expressing the envelope glycoprotein of an avian reticuloendotheliosis retrovirus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5505941A (en) * 1981-12-24 1996-04-09 Health Research, Inc. Recombinant avipox virus and method to induce an immune response
JP2531729B2 (ja) * 1987-03-27 1996-09-04 日本ゼオン株式会社 組み換えアビポックスウイルス
US5286639A (en) * 1987-09-16 1994-02-15 Nippon Zeon Co., Ltd. Recombinant avipoxvirus
FR2632863B2 (fr) * 1987-10-29 1990-08-31 Transgene Sa Virus du fowlpox recombinant et vaccins derives de ces virus
GB8917059D0 (en) * 1989-07-26 1989-09-13 Nat Res Dev Avipox virus promoters

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988000971A1 (en) * 1986-08-01 1988-02-11 Commonwealth Scientific And Industrial Research Or Recombinant vaccine
US5258294A (en) * 1988-02-12 1993-11-02 Commonwealth Scientific And Industrial Research Organisation Bidirectional pox virus promoter element
EP0520753A1 (de) * 1991-06-28 1992-12-30 THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF AGRICULTURE Rekombinante Geflügelpockenvazzine zum Schutz gegen die Marek-Krankheit
WO1994016716A1 (en) * 1993-01-21 1994-08-04 Virogenetics Corporation Recombinant virus immunotherapy
US5403582A (en) * 1993-01-21 1995-04-04 Nippon Zeon Co., Ltd. Vaccine comprising fowlpox virus recombinants expressing the envelope glycoprotein of an avian reticuloendotheliosis retrovirus
WO1994019015A1 (en) * 1993-02-26 1994-09-01 Syntro Corporation Recombinant fowlpox viruses and uses thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BOURSNELL ET AL: "Avipoxvirus vectors", RECOMBINANT POXVIRUSES, XX, XX, June 1992 (1992-06-01), pages 269 - 283, XP002090113 *
BOYLE D B ET AL: "RECOMBINANT FOWLPOX VIRUS VACCINES FOR POULTRY", IMMUNOLOGY AND CELL BIOLOGY, CARLTON, AU, vol. 71, no. PART 5, 1 October 1993 (1993-10-01), pages 391 - 397, XP000609353 *
LEONG KAH HOO ET AL: "Selective induction of immune responses by cytokines coexpressed in recombinant fowlpox virus.", JOURNAL OF VIROLOGY, vol. 68, no. 12, 1994, pages 8125 - 8130, XP001094774, ISSN: 0022-538X *
See also references of WO9640880A1 *

Also Published As

Publication number Publication date
AU6481996A (en) 1996-12-30
EP0832197A1 (de) 1998-04-01
AU729518B2 (en) 2001-02-01
JPH11507241A (ja) 1999-06-29
WO1996040880A1 (en) 1996-12-19
CA2223591A1 (en) 1996-12-19

Similar Documents

Publication Publication Date Title
HUP9802217A3 (en) Recombinant mva virus, and the use thereof
IL122428A0 (en) Minizymes and minribozymes and uses thereof
IL128529A0 (en) Anti-inflammatory peptides and uses thereof
IL112860A0 (en) Recombinant viruses their preparation and their therapeutic uses
EP0973924A4 (de) Rekombinante chimäre viren und deren verwendungen
AU3119895A (en) Recombinant virus vectors
GB9608130D0 (en) Adam proteins and uses thereof
ZA9610721B (en) Grapevine leafroll virus proteins and their uses.
HUP9902710A3 (en) Recombinant swinepox virus
GB9806806D0 (en) Peptides and uses thereof
GB9705903D0 (en) VP22 Proteins and uses thereof
EP0696204A4 (de) Rekombinierter geflügelpockenvirus und seine verwendung
PL318017A1 (en) Peptides
GB9500601D0 (en) Modified peptides
EP0832197A4 (de) Rekombinantes geflügelpockenvirus und seine verwendungsmöglichkeiten
HUP0003327A3 (en) Grapevine leafroll virus (type 2) proteins and their uses
EP0710120A4 (de) Rekombinanter schweinepoxen-virus
GB9423372D0 (en) Proteins and their uses
HUP9801330A3 (en) Novel pka-binding proteins and uses thereof
GB9425380D0 (en) Peptides
IL113725A0 (en) Preparing recombinant aprotini and its variants
KR960010685A (ko) 펩티드 및 그 용도
GB2336844B (en) Anti-hiv peptides and proteins
AU2168795A (en) Recombinant Gibberellin DNA and uses thereof
IL118324A0 (en) Immunoregulatory polypeptide and its uses

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980107

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20020830

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20030807

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040218